BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 1, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 26, 2005
View Archived Issues
Favorable results reported for pegaptanib in wet AMD and DME
Read More
AstraZeneca recaps Q1 developments
Read More
DA-7218: a novel antimycobacterial agent
Read More
AN-53 exerts antiopiate activity in vitro and in vivo
Read More
Update on the Na-ASP-2 vaccine for hookworm infection
Read More
Interferon gamma-1b found to reduce mortality in patients with IPF
Read More
AnGes inlicenses nonviral gene delivery technology from Vical
Read More
Salmedix obtains license to anticancer drug technology from Myriad Genetics
Read More
NRP-104 reaches primary and secondary endpoints in phase III ADHD trial
Read More
Razadyne ER once-daily now available
Read More
Macugen approved in Canada and Brazil
Read More
Phase II study of MN-001 in interstitial cystitis begins
Read More
Patient enrollment complete in phase IIa trial with rNAPc2 for ACS
Read More
Preclinical data on TZP-101, a novel GHS-R1a agonist, for the treatment of gastric motility disorder
Read More
Cytheris acquires license to new immunomodulating agent activating NKT cells
Read More
HCV-796 moves into phase Ib trial in hepatitis C patients
Read More
First patient treated in phase I/II trial of NF-kappaB Decoy
Read More
Isis and Pfizer form ophthalmic antisense drug discovery collaboration
Read More
IKK2 inhibitors prevent inflammatory mediator expression: potential efficacy against asthma
Read More
Antiasthma efficacy of the novel syncretic CRx-170 shown in preclinical studies
Read More
NAALADase inhibitor delays prostate cancer growth and reduces taxol-induced neuropathy in mice
Read More
Unbalanced chromosome arm 11q loss of heterozygosity predicts pediatric neuroblastoma outcome
Read More
Alcon receives approvable letter from FDA for Retaane AMD treatment
Read More
Phase II ONO-2506 study discontinued
Read More
Encysive Pharmaceuticals submits NDA for Thelin
Read More
Data on dapoxetine for premature ejaculation presented at AUA
Read More
PT-141 increases sildenafil efficacy in erectile dysfunction
Read More
Telomerase reverse transcriptase vaccination active in metastatic prostate cancer
Read More
Recent patents cover novel treatments for cognitive disorders
Read More
New agents for treating obesity disclosed by Bristol-Myers Squibb
Read More
Recent patents report novel agents for lipoprotein disorders
Read More
